http://medicalxpress.com/ en-us Medical Xpress provides the latest news from New York- Presbyterian Hospital Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL (ABC-DLBCL), remains a major therapeutic challenge. An international research team, led by two laboratories from Weill Cornell Medical College, has developed a new experimental drug therapy to target this aggressive form of lymphoma. http://medicalxpress.com/news/2012-12-drug-therapy-aggressive-non-hodgkin-lymphoma.html Cancer Mon, 10 Dec 2012 15:46:52 EST news274376793 Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes. As a result, scientists may be able to improve existing antibiotics and design new, smarter ones to fight deadly infections, such as tuberculosis. The new study was published in today's early online edition of Science. http://medicalxpress.com/news/2012-11-mass-spectrometry-antibiotics-tuberculosis-bacteria.html Medical research Thu, 01 Nov 2012 14:03:39 EST news270997385 Patients with hypertension whose blood pressure cannot be brought down to safe levels despite taking three or more medications may have some relief coming their way. An innovative, first-of-its-kind clinical trial for a device representing a dramatic shift in treatment approaches for the toughest-to-treat patients is currently being conducted at NewYork-Presbyterian Hospital. http://medicalxpress.com/news/2012-10-ny-presbyterian-hospital-trial-hard-to-treat-hypertension.html Cardiology Thu, 25 Oct 2012 13:04:45 EST news270389075 A new study by Weill Cornell Medical College researchers, published in the Journal of General Internal Medicine, provides compelling evidence that electronic health records (EHRs) enhance the quality of patient care in a community-based setting with multiple payers, which is representative of how medicine is generally practiced across the United States. http://medicalxpress.com/news/2012-10-electronic-health-shown-quality-patient.html Health Tue, 09 Oct 2012 11:21:48 EST news269000501 Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers led by psychologists at Weill Cornell Medical College. http://medicalxpress.com/news/2012-10-definition-autism-dsm-exclude-children.html Autism spectrum disorders Tue, 02 Oct 2012 00:00:03 EST news268331950 A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by a threat, the ability to suppress an emotional response to the threat is diminished which may explain the peak in anxiety and stress-related disorders during this developmental period. http://medicalxpress.com/news/2012-09-difficult-teens.html Psychology & Psychiatry Thu, 27 Sep 2012 13:28:59 EST news267971302 The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research. http://medicalxpress.com/news/2012-09-reveal-underlying-mechanism-powerful-chemotherapy.html Cancer Mon, 17 Sep 2012 17:03:33 EST news267120203 An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory—a feat few currently approved TB drugs can do, and resistance to those is spreading. http://medicalxpress.com/news/2012-09-pain-drug-resistant-tuberculosis.html Diseases, Conditions, Syndromes Mon, 10 Sep 2012 16:20:05 EST news266512213 An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory—a feat few currently approved TB drugs can do, and resistance to those is spreading. http://medicalxpress.com/news/2012-09-pain-drug-resistant-tuberculosis.html Diseases, Conditions, Syndromes Mon, 10 Sep 2012 16:20:05 EST news266512213 A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal—such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis. http://medicalxpress.com/news/2012-09-drug-combo-abnormal-blood-vessel.html Medical research Mon, 10 Sep 2012 12:00:12 EST news266490976 Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows the cost-effectiveness of integrating on-site rapid HIV testing into drug treatment programs. http://medicalxpress.com/news/2012-09-cost-effectiveness-hiv-drug-abuse-treatment.html HIV & AIDS Sun, 09 Sep 2012 14:43:17 EST news266420590 (Medical Xpress)—Your high school graduate is off to college to embark on a newly independent life. But they're not the only one making a transition: parents too face emotional and lifestyle adjustments. With advice on empty-nest syndrome and the college transition, NewYork-Presbyterian Hospital physicians offer expert tips for parents and children on topics including redecorating your child's room, credit cards, keeping in touch and more. http://medicalxpress.com/news/2012-08-grown-good-advice-empty-nest-syndrome.html Psychology & Psychiatry Thu, 30 Aug 2012 08:05:23 EST news265532718 Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies. http://medicalxpress.com/news/2012-08-doctors-hard-to-diagnose-prostate-cancer.html Cancer Thu, 09 Aug 2012 00:00:01 EST news263661779 Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction. http://medicalxpress.com/news/2012-06-anti-body-vaccine-blocks-addictive-nicotine.html Medical research Wed, 27 Jun 2012 14:00:07 EST news260010070 Weill Cornell Medical College researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then deliver the final knock-out punch to win the fight. http://medicalxpress.com/news/2012-06-cancer-cell-weakens-defeats-multiple.html Cancer Thu, 21 Jun 2012 14:20:36 EST news259507229